• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子 XIII 拓扑结构:用单分子原子力显微镜研究 B 亚基的组织和激活时的变化。

Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

机构信息

Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Border Biomedical Research Center, Department of Biological Sciences, University of Texas at El Paso, El Paso, TX, USA.

出版信息

J Thromb Haemost. 2019 May;17(5):737-748. doi: 10.1111/jth.14412. Epub 2019 Mar 14.

DOI:10.1111/jth.14412
PMID:30773828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6917434/
Abstract

Essentials Factor XIII is a heterotetramer with 2 catalytic A subunits and 2 non-catalytic B subunits. Structure of active and inactive factor XIII was studied with atomic force microscopy. Inactive factor XIII is made of an A globule and 2 flexible B subunits extending from it. Activated factor XIII separates into a B homodimer and 2 monomeric active A subunits. SUMMARY: Background Factor XIII (FXIII) is a precursor of the blood plasma transglutaminase (FXIIIa) that is generated by thrombin and Ca and covalently crosslinks fibrin to strengthen blood clots. Inactive plasma FXIII is a heterotetramer with two catalytic A subunits and two non-catalytic B subunits. Inactive A subunits have been characterized crystallographically, whereas the atomic structure of the entire FXIII and B subunits is unknown and the oligomerization state of activated A subunits remains controversial. Objectives Our goal was to characterize the (sub)molecular structure of inactive FXIII and changes upon activation. Methods Plasma FXIII, non-activated or activated with thrombin and Ca , was studied by single-molecule atomic force microscopy. Additionally, recombinant separate A and B subunits were visualized and compared with their conformations and dimensions in FXIII and FXIIIa. Results and Conclusions We showed that heterotetrameric FXIII forms a globule composed of two catalytic A subunits with two flexible strands comprising individual non-catalytic B subunits that protrude on one side of the globule. Each strand corresponds to seven to eight out of 10 tandem repeats building each B subunit, called sushi domains. The remainder were not seen, presumably because they were tightly bound to the globular A dimer. Some FXIII molecules had one or no visible strands, suggesting dissociation of the B subunits from the globular core. After activation of FXIII with thrombin and Ca , B subunits dissociated and formed B homodimers, whereas the activated globular A subunits dissociated into monomers. These results characterize the molecular organization of FXIII and changes with activation.

摘要

凝血因子 XIII 是一种由 2 个催化 A 亚基和 2 个非催化 B 亚基组成的杂四聚体。使用原子力显微镜研究了活性和非活性凝血因子 XIII 的结构。非活性凝血因子 XIII 由 A 球和从其延伸的 2 个柔性 B 亚基组成。激活的凝血因子 XIII 分离成 B 同源二聚体和 2 个单体活性 A 亚基。

背景

凝血因子 XIII (FXIII) 是血浆转谷氨酰胺酶 (FXIIIa) 的前体,由凝血酶和 Ca 生成,并通过共价交联将纤维蛋白交联以增强血凝块。非活性血浆 FXIII 是一种由两个催化 A 亚基和两个非催化 B 亚基组成的杂四聚体。非活性 A 亚基已通过晶体学进行了表征,而整个 FXIII 和 B 亚基的原子结构未知,并且激活的 A 亚基的寡聚化状态仍存在争议。

目的

我们的目标是表征非活性 FXIII 的(亚)分子结构及其在激活时的变化。

方法

使用单分子原子力显微镜研究了血浆 FXIII、非激活或用凝血酶和 Ca 激活的 FXIII。此外,还对重组的单独 A 和 B 亚基进行了可视化,并将其构象与 FXIII 和 FXIIIa 中的构象和尺寸进行了比较。

结果和结论

我们表明,杂四聚体 FXIII 形成一个由两个催化 A 亚基组成的球,两个柔性链由单独的非催化 B 亚基组成,这些亚基在球的一侧突出。每个链对应于构建每个 B 亚基的 10 个串联重复中的 7 到 8 个,称为 sushi 结构域。其余部分没有被看到,可能是因为它们与球形 A 二聚体紧密结合。一些 FXIII 分子只有一个或没有可见的链,这表明 B 亚基从球形核心解离。用凝血酶和 Ca 激活 FXIII 后,B 亚基解离形成 B 同源二聚体,而激活的球形 A 亚基解离成单体。这些结果表征了 FXIII 的分子组织及其与激活的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/01aba51c6a2f/nihms-1030794-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/3fea36cfb096/nihms-1030794-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/c5fb2c70db7d/nihms-1030794-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/93eb7ab49c7a/nihms-1030794-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/f75447636275/nihms-1030794-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/8683a020ec06/nihms-1030794-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/37f6b636d65d/nihms-1030794-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/01aba51c6a2f/nihms-1030794-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/3fea36cfb096/nihms-1030794-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/c5fb2c70db7d/nihms-1030794-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/93eb7ab49c7a/nihms-1030794-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/f75447636275/nihms-1030794-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/8683a020ec06/nihms-1030794-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/37f6b636d65d/nihms-1030794-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441c/6917434/01aba51c6a2f/nihms-1030794-f0007.jpg

相似文献

1
Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.因子 XIII 拓扑结构:用单分子原子力显微镜研究 B 亚基的组织和激活时的变化。
J Thromb Haemost. 2019 May;17(5):737-748. doi: 10.1111/jth.14412. Epub 2019 Mar 14.
2
The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.血浆因子 XIII 四聚体复合物结构:在对称复合物中出现意想不到的不等配对。
Biomolecules. 2019 Nov 21;9(12):765. doi: 10.3390/biom9120765.
3
Factor XIII: novel structural and functional aspects.凝血因子 XIII:新的结构和功能方面。
J Thromb Haemost. 2011 Jan;9(1):9-20. doi: 10.1111/j.1538-7836.2010.04070.x.
4
Interaction of factor XIII subunits.因子 XIII 亚基的相互作用。
Blood. 2014 Mar 13;123(11):1757-63. doi: 10.1182/blood-2013-10-533596. Epub 2014 Jan 9.
5
Activation of factor XIII is accompanied by a change in oligomerization state.因子 XIII 的激活伴随着寡聚化状态的改变。
FEBS J. 2017 Nov;284(22):3849-3861. doi: 10.1111/febs.14272. Epub 2017 Oct 3.
6
Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking.抗因子 XIII 非催化 B 亚单位抗体抑制因子 XIII 的活化和纤维蛋白交联。
Thromb Haemost. 2023 Sep;123(9):841-854. doi: 10.1055/a-2057-8710. Epub 2023 Mar 19.
7
The role of β-barrels 1 and 2 in the enzymatic activity of factor XIII A-subunit.β-桶 1 和 2 在因子 XIII A 亚基酶活性中的作用。
J Thromb Haemost. 2018 Jul;16(7):1391-1401. doi: 10.1111/jth.14128. Epub 2018 May 27.
8
The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.凝血因子 XIII 的非催化 B 亚基可加速纤维蛋白交联。
J Biol Chem. 2015 May 8;290(19):12027-39. doi: 10.1074/jbc.M114.608570. Epub 2015 Mar 25.
9
Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.转谷氨酰胺酶(因子 XIII)介导的纤维蛋白原和纤维蛋白交联。
Thromb Haemost. 2001 Nov;86(5):1221-8.
10
The activation peptide of coagulation factor XIII is vital for its expression and stability.凝血因子 XIII 的激活肽对于其表达和稳定性至关重要。
J Thromb Haemost. 2015 Aug;13(8):1449-58. doi: 10.1111/jth.13035. Epub 2015 Jul 16.

引用本文的文献

1
Retroperitoneal fibrosis in presence of autoimmune coagulation factor XIII deficiency result in recurrent critical post-operative hemorrhage: a case report and molecular research with new insights.自身免疫性凝血因子 XIII 缺乏症患者的腹膜后纤维化导致术后反复严重出血:一例报告及有新见解的分子研究
Front Immunol. 2025 Jul 10;16:1591847. doi: 10.3389/fimmu.2025.1591847. eCollection 2025.
2
Another cryo-EM success: structure of FXIII.冷冻电镜的又一成功:凝血因子 XIII 的结构
Blood. 2025 Jan 23;145(4):356-357. doi: 10.1182/blood.2024027405.
3
Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration.

本文引用的文献

1
Let's cross-link: diverse functions of the promiscuous cellular transglutaminase factor XIII-A.让我们交联起来:多功能细胞转谷氨酰胺酶因子 XIII-A。
J Thromb Haemost. 2019 Jan;17(1):19-30. doi: 10.1111/jth.14348.
2
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.血浆中的因子 XIII,而不是血小板,介导了红细胞在血栓中的滞留和静脉血栓的大小。
Blood Adv. 2018 Jan 3;2(1):25-35. doi: 10.1182/bloodadvances.2017011890. eCollection 2018 Jan 9.
3
Activation of factor XIII is accompanied by a change in oligomerization state.
凝血因子 XIII-A 和 -B 亚基的相互稳定是血浆 FXIII 浓度的决定因素。
Blood. 2024 Feb 1;143(5):444-455. doi: 10.1182/blood.2023022042.
4
Antioxidant role of methionine-containing intra- and extracellular proteins.含蛋氨酸的细胞内和细胞外蛋白质的抗氧化作用。
Biophys Rev. 2023 Apr 10;15(3):367-383. doi: 10.1007/s12551-023-01056-7. eCollection 2023 Jun.
5
The Structure of Blood Coagulation Factor XIII Is Adapted to Oxidation.凝血因子 XIII 结构适应氧化。
Biomolecules. 2020 Jun 17;10(6):914. doi: 10.3390/biom10060914.
6
The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.血浆因子 XIII 四聚体复合物结构:在对称复合物中出现意想不到的不等配对。
Biomolecules. 2019 Nov 21;9(12):765. doi: 10.3390/biom9120765.
7
Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a).新型抑制剂ZED3197作为靶向凝血因子FXIIIa(F13a)的抗凝潜在候选药物。
J Thromb Haemost. 2020 Jan;18(1):191-200. doi: 10.1111/jth.14646. Epub 2019 Oct 23.
因子 XIII 的激活伴随着寡聚化状态的改变。
FEBS J. 2017 Nov;284(22):3849-3861. doi: 10.1111/febs.14272. Epub 2017 Oct 3.
4
Morphometric characterization of fibrinogen's αC regions and their role in fibrin self-assembly and molecular organization.纤维蛋白原 αC 区的形态特征及其在纤维蛋白自组装和分子组织中的作用。
Nanoscale. 2017 Sep 21;9(36):13707-13716. doi: 10.1039/c7nr04413e.
5
Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.重组纤维蛋白原揭示了 α 链和 γ 链交联及分子异质性在纤维蛋白凝块应变硬化中的差异作用。
J Thromb Haemost. 2017 May;15(5):938-949. doi: 10.1111/jth.13650. Epub 2017 Mar 6.
6
Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective.从结构/功能角度重新审视凝血因子XIII激活与调控机制。
Sci Rep. 2016 Jul 25;6:30105. doi: 10.1038/srep30105.
7
Blood coagulation factor XIII and factor XIII deficiency.血液凝固因子 XIII 与因子 XIII 缺乏症
Blood Rev. 2016 Nov;30(6):461-475. doi: 10.1016/j.blre.2016.06.002. Epub 2016 Jun 16.
8
Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.凝块收缩的动力学和力学受血液的分子和细胞组成支配。
Blood. 2016 Jan 7;127(1):149-59. doi: 10.1182/blood-2015-05-647560. Epub 2015 Nov 24.
9
Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.凝血因子XIIIa依赖的红细胞在凝块中的滞留是由纤维蛋白α链交联介导的。
Blood. 2015 Oct 15;126(16):1940-8. doi: 10.1182/blood-2015-06-652263. Epub 2015 Aug 31.
10
Visualization of fibrinogen αC regions and their arrangement during fibrin network formation by high-resolution AFM.利用高分辨率原子力显微镜观察纤维蛋白原 αC 区及其在纤维蛋白网络形成过程中的排列。
J Thromb Haemost. 2015 Apr;13(4):570-9. doi: 10.1111/jth.12785. Epub 2015 Jan 27.